e-learning
resources
Munich 2006
Sunday 03.09.2006
Cystic fibrosis: aerosol treatment and non–pulmonary complications
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Control of the inhalation technique in cystic fibrosis patients
J. C. Dubus, A. Clavel, A. Deschildre, S. Ravilly (Marseille, France)
Source:
Annual Congress 2006 - Cystic fibrosis: aerosol treatment and non–pulmonary complications
Session:
Cystic fibrosis: aerosol treatment and non–pulmonary complications
Session type:
Thematic Poster Session
Number:
1519
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. C. Dubus, A. Clavel, A. Deschildre, S. Ravilly (Marseille, France). Control of the inhalation technique in cystic fibrosis patients. Eur Respir J 2006; 28: Suppl. 50, 1519
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
The assesment of aerosol solution lung deposition in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 584s
Year: 2004
Inhalation therapy in cystic fibrosis
Source: School Course 2013 - Cystic Fibrosis
Year: 2013
NIV for children with cystic fibrosis
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017
Airway clearance techniques in cystic fibrosis
Source: Eur Respir J 2006; 27: 1082-1083
Year: 2006
Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations
Source: Eur Respir J 2015; 46: 1055-1064
Year: 2015
How useful is the lung ultrasound in cystic fibrosis?
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018
Pregnancy in two patients with cystic fibrosis treated with lumacaftor/ivacaftor
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019
Single-breath washout and association with structural lung changes in children with cystic fibrosis
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016
Two-compartment model of gas mixing in patients with asthma and cystic fibrosis
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013
Lung Clearance Index (LCI) and FEV
1
on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014
Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014
Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept